BMC Genomics Impact Factor

The title check matters because BMC is a publisher family, not one journal.

BMC Genomics is the open-access journal that Springer Nature describes as

covering genetics, genomics, and proteomics, including genome-scale analysis,

functional genomics, epigenomics, and transcriptomics. Its electronic ISSN is

1471-2164.

Do not transfer this metric to a title with similar words, including Genome

Biology, BMC Bioinformatics, BMC Medicine, or another BMC journal. Each has

its own scope, identifier, and journal metrics. The [best genetics journals

guide](/blog/best-genetics-journals) is useful for a broader route choice; this

page is only the exact BMC Genomics metric owner.

The two values are not competing scores. They measure journal-level citation

activity over different windows. A five-year JIF can be useful when a field's

citations accumulate less quickly, but it does not make the journal a better

or worse destination for an individual paper.

The more useful manuscript questions are narrower:

The common error is a publisher-family collision: a reader sees "BMC" in

a result and assumes every title has the same scope, metric, or editorial

expectations. The exact title and ISSN stop that mistake before the metric is

used in a CV, comparison, or journal shortlist.

The named failure pattern on this query is a record that has the right

publisher family but the wrong journal. We map the exact title, eISSN, data

year, release context, and source before interpreting the number. That is more

useful than a generic prestige ranking because it makes the lookup auditable:

another researcher can reopen the official profile, check the same fields, and

see which claims the page does and does not support.

The secondary exact-title record reports a 2024 JIF of 3.7 and a **2025

JIF of 3.9**, an increase of 0.2. Treat this as a labeled cross-check of the

year-over-year change, not as a replacement for the official current 3.9

display or a prediction about future citations. Its listed h-index of 260

is a lifetime database metric, so it should not be compared directly with an

annual JIF.

The official profile supports a current snapshot: BMC Genomics is an

open-access Springer Nature journal with a 2025 JIF of 3.9, a five-year JIF of

4.4, and a publisher-displayed median four-day first decision. It does not

establish an acceptance rate, a publication fee, an annual JIF trend, or the

outcome of an individual submission. Those claims need their own current

sources and should not be inferred from a metric table.

That limitation matters most when a number is used as a proxy for manuscript

quality. A JIF describes a journal-level citation pattern. It cannot test

whether a dataset is reusable, whether the analysis answers a genomics

question, whether methods are reproducible, or whether the abstract makes the

contribution legible to the intended readers. Those are manuscript-level

questions that the metric does not answer.

This page does not publish an annual JIF trend because the current official

public profile provides a present-tense metric snapshot, not a verified

year-by-year series. A historical chart should be built only from a source that

identifies every data year and its provenance, such as the appropriate JCR

access route. The evidence here supports the 2025 JIF of 3.9 and five-year JIF

of 4.4; it does not support an inferred rise, fall, or multi-year narrative.

Springer Nature displays a median 4-day submission-to-first-decision

statistic. It is useful as a current aggregate planning signal, especially

when an author needs to distinguish an initial editorial outcome from the full

publication process. It is not a service guarantee, a review-time estimate,

or an acceptance prediction.

Do not plan a grant deadline, thesis submission, or competing-journal decision

on the assumption that every paper will receive the same timing. Individual

outcomes depend on the manuscript, editorial handling, reviewer recruitment,

and revision needs. Use the live publisher workflow for the next action and

keep the aggregate metric labeled as a median.

If the open question is whether the manuscript's genomics contribution is

ready for its intended journal audience, a [manuscript readiness

check](/ai-review?source_blog=bmc-genomics-impact-factor&primary_concern=journal_fit)

can evaluate that manuscript-level decision. The JIF itself cannot.

• Match BMC Genomics and eISSN 1471-2164, rather than relying on a BMC

publisher label alone.

• Describe the number as a 2025 JIF of 3.9 released in 2026.
• Keep the five-year JIF (4.4) separate from the two-year JIF (3.9).
• Use the current Springer Nature profile for the present metric and the

institution's required JCR route for formal bibliometrics.

• Verify scope, article type, fee, and submission-policy questions directly on

the current author guidance; they are separate from a metric lookup.

For route selection, compare the manuscript with the [best genetics journals

guide](/blog/best-genetics-journals), the [Genome Biology submission

guide](/blog/genome-biology-submission-guide), and the [journal selection

guide](/blog/how-to-choose-a-journal-for-your-research-paper). Those pages

answer different reader jobs and should not compete for this metric query.